NASDAQ:CLPT ClearPoint Neuro Q3 2026 Earnings Date & Estimates $9.07 -0.57 (-5.91%) Closing price 04:00 PM EasternExtended Trading$9.11 +0.04 (+0.43%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ClearPoint Neuro is estimated to report Q3 2026 earnings on Wednesday, October 28, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateOctober 28, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from ClearPoint Neuro in Q3 2026ClearPoint Neuro is expected to post earnings of -$0.27 per share on revenue of $12.30 million. In the same quarter a year earlier ClearPoint Neuro reported -$0.21 per share on revenue of $5.36 million. ClearPoint Neuro last reported on August 3, 2026, posting -$0.38 per share and missing the -$0.2867 consensus estimate. ClearPoint Neuro has beaten the consensus EPS estimate in 0 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.27Expected Revenue$12.30 millionPrior-Year EPS-$0.21Prior-Year Revenue$5.36 millionExpected Revenue Growth+129.4%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.38 (Missed by -$0.0933)Last Quarter Revenue$10.88 millionEPS Beat Rate0 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report ClearPoint Neuro Q3 2026 Earnings FAQ When does ClearPoint Neuro report Q3 2026 earnings? ClearPoint Neuro (NASDAQ:CLPT) is estimated to report Q3 2026 earnings on Wednesday, October 28, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is ClearPoint Neuro's Q3 2026 earnings call? ClearPoint Neuro's Q3 2026 earnings conference call is scheduled for Wednesday, October 28, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for ClearPoint Neuro? Analysts expect ClearPoint Neuro to post earnings of -$0.27 per share for Q3 2026. How much revenue is ClearPoint Neuro expected to report? The consensus revenue estimate for ClearPoint Neuro is $12.30 million for Q3 2026. ClearPoint Neuro Earnings HeadlinesINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPTOctober 15 at 10:00 AM | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPTOctober 13 at 5:49 PM | globenewswire.comUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares still trade under 1 dollar. It just signed the largest transaction in its history, a new gold streaming deal backed by a strategic relationship with a major mining investment firm. A well-known sector financier has invested his own money and joins the CEO in an exclusive interview breaking down the full story.October 16 at 1:00 AM | Digest Publishing (Ad)INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPTOctober 8, 2026 | prnewswire.comCLPT Investors with $100,000 in Losses Have Opportunity to Join ClearPoint Neuro, Inc. Fraud Investigation with SBS LawOctober 7, 2026 | businesswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPTOctober 6, 2026 | globenewswire.comSee More ClearPoint Neuro Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like ClearPoint Neuro? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ClearPoint Neuro and other key companies, straight to your email. Email Address About ClearPoint NeuroClearPoint Neuro (NASDAQ:CLPT) is a medical technology company that develops and commercializes image-guided systems for minimally invasive neurosurgical procedures. Its platform is designed to help physicians plan, navigate and monitor procedures within the brain, using magnetic resonance imaging (MRI) to support accurate placement of instruments and therapeutic agents. The company’s product portfolio includes the ClearPoint Neuro navigation system and related disposable components, including cranial access and guidance products. These technologies are used in procedures such as biopsies, laser ablation, deep brain stimulation lead placement and the delivery of drugs or gene therapies directly to targeted areas of the brain. ClearPoint Neuro also provides planning, software and procedural support services for hospitals, research institutions and pharmaceutical or biotechnology companies developing neurological treatments. The company was formerly known as MRI Interventions, Inc. and adopted the ClearPoint Neuro name in 2020. Its technologies are used primarily in the United States, with international activities supported through commercial and research relationships. ClearPoint Neuro is headquartered in Solana Beach, California, and serves the neurosurgical, pharmaceutical and biotechnology markets.View ClearPoint Neuro ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Bank of America Stock Sell-Off Looks Like a Buying OpportunityMorgan Stanley Beats on Earnings, But Shares Fall on Trading MixFundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?Palantir's Potential Next Catalyst After Retail Profit-TakingApple Cut iPhone 18 Orders; What Does It Mean For Suppliers?Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But UpFastenal Flashes Bullish Signal as Uptrend Holds Despite Margin Pressure Upcoming Earnings HDFC Bank (10/17/2026)ICICI Bank (10/17/2026)America Movil (10/20/2026)Netflix (10/20/2026)General Motors (10/20/2026)Chubb (10/20/2026)Capital One Financial (10/20/2026)Intuitive Surgical (10/20/2026)GE Aerospace (10/20/2026)3M (10/20/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
